Welcome to LookChem.com Sign In|Join Free

CAS

  • or

51131-55-6

Post Buying Request

51131-55-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

51131-55-6 Usage

Chemical compound

4-(2-amino-2-methylpropyl)aniline

Derivative of

Aniline

Substituent

Propylamine on the amino group

Applications

Production of dyes, pharmaceuticals, rubber chemicals, reagent in organic synthesis, intermediate in manufacturing industrial products

Health hazards

Should be handled with caution

Check Digit Verification of cas no

The CAS Registry Mumber 51131-55-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,1,3 and 1 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 51131-55:
(7*5)+(6*1)+(5*1)+(4*3)+(3*1)+(2*5)+(1*5)=76
76 % 10 = 6
So 51131-55-6 is a valid CAS Registry Number.

51131-55-6Relevant articles and documents

A multivalent approach to the discovery of long-acting β2- adrenoceptor agonists for the treatment of asthma and COPD

Jacobsen, John R.,Choi, Seok Ki,Combs, Jesse,Fournier, Eric J.L.,Klein, Uwe,Pfeiffer, Juergen W.,Thomas, G. Roger,Yu, Cecile,Moran, Edmund J.

, p. 1213 - 1218 (2012/03/11)

A multivalent approach was applied to the design of long-acting inhaled β2-adrenoceptor agonists. A series of dimeric arylethanolamines based on the short acting β2-adrenoceptor agonist albuterol were prepared, varying the nature and length of the linker between the basic nitrogens. None of the C2-symmetric dimers demonstrated increased potency, however dimer 5j, derived from 4-phenethylamine, was found to have increased binding potency in vitro relative to the parent monomer. Optimization of this structure led to the identification of 22 (milveterol) which demonstrates high potency in vitro and long duration of action in a guinea pig model of bronchoprotection.

Aryl aniline derivatives as beta2 adrenergic receptor agonists

-

Page/Page column 19, (2008/06/13)

The invention provides novel β2 adrenergic receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with β2 adrenergic

Cu2+/BH4- REDUCTION SYSTEM: SYNTHETIC UTILITY AND MODE OF ACTION

Cowan, J. A.

, p. 1205 - 1208 (2007/10/02)

Cu2+/BH4- offers a mild, method of reduction for aromatic and aliphatic tertiary nitro groups.Its mode of action has been studied, in comparison with related reagents, by deuterium isotope experiments.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 51131-55-6